株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血糖値計:パイプライン分析

Blood Glucose Meters - Medical Devices Pipeline Assessment, 2018

発行 GlobalData 商品コード 328675
出版日 ページ情報 英文 503 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.58円で換算しております。
Back to Top
血糖値計:パイプライン分析 Blood Glucose Meters - Medical Devices Pipeline Assessment, 2018
出版日: 2018年05月01日 ページ情報: 英文 503 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発中の血糖値計のパイプライン製品情報について分析し、治験/製品開発の全体的な進行状況や、段階別・地域別・分野別の詳細動向、企業別・製品別の詳細情報 (治験の進行段階、開始/終了時期、認証見通しなど)、昨今の開発・資本取引の動きなどを盛り込んでお届けいたします。

目次

  • イントロダクション
    • 血糖値計の概略
  • 開発中の製品
    • パイプライン製品:開発段階別
    • パイプライン製品:セグメント別
    • パイプライン製品:地域別
    • パイプライン製品:規制経路別
    • パイプライン製品:認証時期 (推定) 別
    • パイプライン製品:進行中の治験
  • 血糖値計:開発中のパイプライン製品 (企業別)
    • 血糖値計の開発企業:パイプライン製品 (開発段階別)
    • 血糖値計:開発段階別のパイプライン製品
  • 血糖値計の開発企業・製品の概要
  • 4a Medicom GmbH
    • パイプライン製品/進行中の治験の概要
  • A*STAR Institute of Microelectronics
  • A. Menarini Diagnostics S.r.l.
  • Abbott Diabetes Care, Inc.
  • Advanced Biosensors-Ohio, Llc
  • Advanced Medical Electronics Corporation
  • AirMarkers
  • Alcon, Inc.
  • Arkal Medical, Inc.
  • Azurite Technologies, Inc.
  • Bar-Ilan University
  • Baylor University
  • Biorasis, Inc.
  • BioTex, Inc.
  • Biovotion AG
  • BlueVine Graphene Industries, Inc.
  • C8 MediSensors, Inc.
  • Capillary Biomedical, Inc.
  • Cardiff University
  • Cascade Metrix, Inc.
  • CGM3 Ltd
  • Cnoga Medical Ltd.
  • ConvaTec Healthcare B S.a.r.l.
  • DexCom, Inc.
  • DIRAmed LLC.
  • Echo Therapeutics, Inc.
  • Elte Sensoric GmbH
  • eLutions Integrated Systems, Inc.
  • EyeSense GmbH
  • Flowsion AS
  • Freedom Meditech, Inc.
  • Gili Medical Ltd
  • Globe Medical Tech, Inc.
  • Glucometrics, Inc.
  • Glucometrix AG
  • Glucosense Diagnostics, Ltd.
  • GlucoSet AS
  • Glucovation, Inc.
  • GluMetrics, Inc.
  • GluSense Ltd.
  • GlySens Incorporated
  • GlySure Ltd
  • Grove Instruments Inc.
  • Hygiena, LLC
  • Hypo-Safe A/S
  • Institute of Biomedical Engineering (ISIB-CNR)
  • Insulet Corporation
  • Integrity Applications Ltd.
  • Intuity Medical, Inc.
  • Invivomon Inc.
  • LabStyle Innovations Corp.
  • Lein Applied Diagnostics Limited
  • LEMM Technologies, LLC
  • LifeScan, Inc.
  • LighTouch Medical, Inc.
  • Maquet Holding B.V. & Co. KG.
  • Massachusetts Institute of Technology
  • MASTInc
  • Medella Health Inc.
  • Medical Wireless Sensing Ltd
  • Medtronic plc
  • Mellitor Ltd.
  • Mendor Oy
  • MicroCHIPS, Inc.
  • mobiLIFE
  • 長崎大学
  • Nemaura Medical Inc
  • Newton Photonics Inc
  • Northwestern University
  • NovioSense B.V.
  • Optiscan Biomedical Corporation
  • Pepex Biomedical, Inc.
  • Pignolo SpA
  • PositiveID Corporation
  • Quick, LLC
  • Senseonics, Incorporated
  • Sentec AG
  • Senzime AB
  • Socrates Health Solutions, Inc.
  • St. Louis Medical Devices, Inc
  • Tandem Diabetes Care, Inc.
  • TecMed, Inc.
  • テルモ
  • The Charles Stark Draper Laboratory Inc
  • The University of Bari Aldo Moro
  • Ultradian Diagnostics LLC
  • University of Bath
  • University of Calgary
  • University of California, Berkeley
  • University of California, San Diego
  • University of South Florida
  • University of Western Ontario
  • Vytrace, Inc.
  • Xhale, Inc.
  • 昨今の動向 (計104件)
  • 付録

図表一覧

目次
Product Code: GDME0540EPD

GlobalData's Medical Devices sector report, "Blood Glucose Meters - Medical Devices Pipeline Assessment, 2018" provides an overview of Blood Glucose Meters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Blood Glucose Meters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Blood Glucose Meters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Blood Glucose Meters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Blood Glucose Meters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 12
  • 1.2 List of Figures 22

2 Introduction 23

  • 2.1 Blood Glucose Meters Overview 23

3 Products under Development 24

  • 3.1 Blood Glucose Meters - Pipeline Products by Stage of Development 24
  • 3.2 Blood Glucose Meters - Pipeline Products by Segment 25
  • 3.3 Blood Glucose Meters - Pipeline Products by Territory 26
  • 3.4 Blood Glucose Meters - Pipeline Products by Regulatory Path 27
  • 3.5 Blood Glucose Meters - Pipeline Products by Estimated Approval Date 28
  • 3.6 Blood Glucose Meters - Ongoing Clinical Trials 29

4 Blood Glucose Meters - Pipeline Products under Development by Companies 30

  • 4.1 Blood Glucose Meters Companies - Pipeline Products by Stage of Development 30
  • 4.2 Blood Glucose Meters - Pipeline Products by Stage of Development 34

5 Blood Glucose Meters Companies and Product Overview 39

  • 5.1 4a Medicom GmbH Company Overview 39
  • 5.2 A. Menarini Diagnostics Srl Company Overview 40
  • 5.3 Abbott Diabetes Care Inc Company Overview 41
  • 5.4 Abbott Diagnostics Company Overview 48
  • 5.5 Advanced Biosensors-Ohio LLC Company Overview 49
  • 5.6 Advanced Medical Electronics Corp Company Overview 50
  • 5.7 Animas Corp Company Overview 51
  • 5.8 Arkal Medical, Inc. (Inactive) Company Overview 52
  • 5.9 Arkray Inc Company Overview 53
  • 5.10 Ascensia Diabetes Care Holdings AG Company Overview 55
  • 5.11 Azurite Technologies, Inc. (Inactive) Company Overview 56
  • 5.12 Bar-Ilan University Company Overview 57
  • 5.13 Baylor University Company Overview 58
  • 5.14 Biopeak Corp Company Overview 59
  • 5.15 Biorasis Inc Company Overview 60
  • 5.16 BioTex Inc Company Overview 61
  • 5.17 Biovotion AG Company Overview 62
  • 5.18 Brain Beat Ltd Company Overview 63
  • 5.19 Brigham and Women's Hospital Company Overview 64
  • 5.20 Cactus Semiconductor Inc Company Overview 65
  • 5.21 CALISTO MEDICAL, INC. (Inactive) Company Overview 66
  • 5.22 Callitas Therapeutics Inc Company Overview 67
  • 5.23 Cardiff University Company Overview 68
  • 5.24 CGM3 Ltd Company Overview 69
  • 5.25 City, University of London Company Overview 70
  • 5.26 Columbia University Company Overview 71
  • 5.27 ConvaTec Group Plc Company Overview 72
  • 5.28 Cyber Medical Ltd Company Overview 73
  • 5.29 DarioHealth Corp Company Overview 74
  • 5.30 Debiotech SA Company Overview 75
  • 5.31 DexCom Inc Company Overview 76
  • 5.32 DiaMonTech GmbH Company Overview 83
  • 5.33 DIRAmed LLC. Company Overview 85
  • 5.34 DirectSens GmbH Company Overview 87
  • 5.35 Drayson Health Ltd Company Overview 88
  • 5.36 Echo Therapeutics Inc Company Overview 89
  • 5.37 Ecole Polytechnique Federale de Lausanne Company Overview 92
  • 5.38 eLutions Integrated Systems, Inc. Company Overview 93
  • 5.39 Emperra GmbH E-Health Technologies Company Overview 94
  • 5.40 EyeSense GmbH Company Overview 95
  • 5.41 Flowsion A/S Company Overview 98
  • 5.42 Gili Medical Ltd Company Overview 99
  • 5.43 Globe Medical Tech Inc Company Overview 100
  • 5.44 GlucoLight Corporation (Inactive) Company Overview 101
  • 5.45 GlucoMe Ltd Company Overview 102
  • 5.46 Glucometrix AG Company Overview 103
  • 5.47 Glucosat Company Overview 104
  • 5.48 Glucosense Diagnostics Ltd (Inactive) Company Overview 105
  • 5.49 GlucoSet AS Company Overview 107
  • 5.50 GlucoStats System Pte Ltd. Company Overview 108
  • 5.51 Glucovation Inc Company Overview 110
  • 5.52 GluMetrics Inc Company Overview 111
  • 5.53 Glusense Ltd Company Overview 112
  • 5.54 GlySens Inc Company Overview 113
  • 5.55 GlySure Ltd Company Overview 117
  • 5.56 Grove Instruments Inc. (Inactive) Company Overview 118
  • 5.57 G-Sense Ltd. Company Overview 119
  • 5.58 iGlyko, Inc. (Inactive) Company Overview 120
  • 5.59 Indian Institute of Technology Bombay Company Overview 121
  • 5.60 Indigo Diabetes NV Company Overview 122
  • 5.61 InLight Solutions Inc. Company Overview 123
  • 5.62 Innovosens AB Company Overview 124
  • 5.63 Innovus Pharmaceuticals Inc Company Overview 125
  • 5.64 Institute of Biomedical Engineering (ISIB-CNR) (Inactive) Company Overview 126
  • 5.65 Insulet Corp Company Overview 127
  • 5.66 Integrated Medical Group of Irvine Company Overview 128
  • 5.67 Integrity Applications Ltd Company Overview 129
  • 5.68 IntelliDx Inc (Inactive) Company Overview 134
  • 5.69 Invivomon Inc (Inactive) Company Overview 135
  • 5.70 Invivosense ASA (Inactive) Company Overview 136
  • 5.71 iSense Corporation (Inactive) Company Overview 137
  • 5.72 KeenCAT Technologies Company Overview 138
  • 5.73 Lein Applied Diagnostics Limited Company Overview 139
  • 5.74 LEMM Technologies, LLC Company Overview 140
  • 5.75 LifeScan Inc Company Overview 141
  • 5.76 LighTouch Medical, Inc. Company Overview 142
  • 5.77 Luminous Medical Inc (Inactive) Company Overview 145
  • 5.78 Lyte Labs Company Overview 146
  • 5.79 Massachusetts Institute of Technology Company Overview 147
  • 5.80 Medical Wireless Sensing Ltd Company Overview 149
  • 5.81 Medtronic plc Company Overview 150
  • 5.82 Mellitor Ltd Company Overview 163
  • 5.83 Metronom Health Inc Company Overview 164
  • 5.84 Microchips Biotech Inc Company Overview 167
  • 5.85 MIT Spectroscopy Lab Company Overview 168
  • 5.86 mobiLIFE Company Overview 169
  • 5.87 Mologic Ltd Company Overview 170
  • 5.88 Nagasaki University Company Overview 171
  • 5.89 Nemaura Medical Inc Company Overview 172
  • 5.90 Newton Photonics Inc Company Overview 174
  • 5.91 NIR Diagnostics Inc. (Inactive) Company Overview 175
  • 5.92 Northwestern University Company Overview 176
  • 5.93 Orsus Medical Ltd Company Overview 177
  • 5.94 Pelikan Technologies, Inc. (Inactive) Company Overview 178
  • 5.95 Pepex Biomedical, Inc. Company Overview 179
  • 5.96 PharmaTech Solutions Inc Company Overview 180
  • 5.97 Pignolo SpA Company Overview 181
  • 5.98 POPS! Diabetes Care Inc Company Overview 182
  • 5.99 PositiveID Corp Company Overview 186
  • 5.100 Prediktor Medical AS Company Overview 188
  • 5.101 Profusa, Inc. Company Overview 189
  • 5.102 Purdue University Company Overview 190
  • 5.103 Q Step Technologies, Inc. Company Overview 191
  • 5.104 Roche Diabetes Care Inc Company Overview 192
  • 5.105 Royal Adelaide Hospital SA Company Overview 193
  • 5.106 RSP Systems A/S Company Overview 194
  • 5.107 San Meditech (Huzhou) Co., Ltd. Company Overview 199
  • 5.108 Senseonics Holdings, Inc. Company Overview 200
  • 5.109 SensiVida Medical Technologies, Inc. (Inactive) Company Overview 204
  • 5.110 Sensys Medical, Inc. Company Overview 205
  • 5.111 Sentec Pte Ltd Company Overview 206
  • 5.112 Senzime AB Company Overview 207
  • 5.113 Shield Diagnostics Company Overview 209
  • 5.114 Singapore Biomicro Pte Ltd Company Overview 210
  • 5.115 Socrates Health Solutions, Inc. Company Overview 211
  • 5.116 Spire Corp Company Overview 212
  • 5.117 St. Louis Medical Devices Inc (Inactive) Company Overview 213
  • 5.118 Stony Brook University Company Overview 214
  • 5.119 TecMed Inc Company Overview 215
  • 5.120 Tenax Therapeutics Inc Company Overview 216
  • 5.121 Terumo Corp Company Overview 217
  • 5.122 Texas A&M University Company Overview 219
  • 5.123 Ultradian Diagnostics LLC Company Overview 220
  • 5.124 University of Bath Company Overview 221
  • 5.125 University of California Berkeley Company Overview 222
  • 5.126 University of California Irvine Company Overview 224
  • 5.127 University of California San Diego Company Overview 225
  • 5.128 University of Central Florida Company Overview 226
  • 5.129 University of South Carolina Company Overview 227
  • 5.130 University of South Florida Company Overview 228
  • 5.131 University of Technology Sydney Company Overview 229
  • 5.132 University of Texas at Arlington Company Overview 230
  • 5.133 Virginia Commonwealth University Company Overview 231
  • 5.134 Vytrace, Inc. Company Overview 232
  • 5.135 WaveForm Technologies Inc Company Overview 233
  • 5.136 Xcellence in Bio Innovations & Technologies Pvt Ltd Company Overview 234
  • 5.137 Zansors LLC Company Overview 235
  • 5.138 Zyvex Corporation Company Overview 236

6 Blood Glucose Meters- Recent Developments 237

  • 6.1 Apr 19, 2018: Roche Diabetes Care Launches the Accu-Chek Guide System and the Unique Spill-Resistant Smartpack Vial 237
  • 6.2 Apr 18, 2018: Abbott Reports First-Quarter 2018 Results 237
  • 6.3 Apr 18, 2018: Veritas Pharma Names Dr. Michael K. Pugsley To Advisory Board 240
  • 6.4 Apr 12, 2018: Innovus Pharma Announces U.S. Food and Drug Administration Clearance of its GlucoGorx Glucose Monitoring Device Test Kit 240
  • 6.5 Apr 12, 2018: Henry Schein Names Christopher Pendergast To Lead Information Technology 241
  • 6.6 Apr 12, 2018: Socrates Health Solutions, Developer of Socrates Companion Noninvasive Blood Glucose Self-Monitoring Device, Announces Expanded Role of John Maynard 242
  • 6.7 Apr 11, 2018: Zealand and Roche Diabetes Care enter Phase 3 study collaboration for treatment of congenital hyperinsulinism with dasiglucagon 242
  • 6.8 Apr 11, 2018: Socrates Companion Noninvasive Blood Glucose Self-Monitoring Device Successfully Measures Extended Ranges for Diabetic Population 243
  • 6.9 Apr 10, 2018: Tandem Diabetes Care Announces Preliminary First Quarter 2018 Results 243
  • 6.10 Apr 10, 2018: Healthcare Technology Veteran Russ Johannesson Joins Glooko as CEO 244
  • 6.11 Apr 10, 2018: Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program Receives 2018 William J. Gies Award 244
  • 6.12 Apr 09, 2018: Henry Schein Names Mark Hillebrandt Vice President, Marketing, North America Dental Group 245
  • 6.13 Apr 09, 2018: Nemaura Medical Appoints Bashir Timol Chief Business Officer 246
  • 6.14 Apr 05, 2018: Sanmina Achieves FDA Registration at Its Facilities in Chennai, India 246
  • 6.15 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 247
  • 6.16 Apr 03, 2018: PositiveID Reports 2017 Results; Fourth Quarter Revenues Increase 47% Year Over Year 248
  • 6.17 Mar 29, 2018: Senseonics Announces Favorable Outcome of FDA Advisory Committee on the Eversense System 249
  • 6.18 Mar 28, 2018: Nemaura Medical Appoints The Ruth Group as Investor and Public Relations Counsel 249
  • 6.19 Mar 28, 2018: Sanofi: Pre - quarterly Results Communication 250
  • 6.20 Mar 27, 2018: FDA Authorizes Marketing of the New Dexcom G6 CGM Eliminating Need for Fingerstick Blood Testing for People with Diabetes 252
  • 6.21 Mar 26, 2018: DarioHealth Receives U.S. FDA Clearance for iPhone 7, 8 and iPhone X Smart Glucose Meter 253
  • 6.22 Mar 26, 2018: Drayson Health: Positive Clinical Trial of GDm-Health 253
  • 6.23 Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros 254
  • 6.24 Mar 22, 2018: Lee's Pharmaceutical Holdings: Announcement Of Annual Results For The Year Ended 31 December 2017 256
  • 6.25 Mar 15, 2018: Veritas Pharma Announces Appointment of Accomplished Business Development and Strategy Professional, Justin Kausel 262
  • 6.26 Mar 14, 2018: EKF Diagnostics Holdings: 2017 Final results 262
  • 6.27 Mar 14, 2018: Tenax Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement 266
  • 6.28 Mar 12, 2018: Medtronic Receives FDA Approval for Guardian Connect Continuous Glucose Monitoring (CGM) System for People Living with Diabetes 267
  • 6.29 Mar 08, 2018: WaveForm Technologies Receives Favorable Decision on Critical Glucose Monitoring Patents 267
  • 6.30 Mar 08, 2018: Changes to the Roche Enlarged Corporate Executive Committee 268
  • 6.31 Mar 08, 2018: Sysmex: Announcement of Organizational and Personnel Changes 269
  • 6.32 Mar 06, 2018: Sanofi's Board of Directors Proposes Appointment of Emmanuel Babeau as New Independent Director 271
  • 6.33 Mar 05, 2018: Henry Ford Health System Appoints Adnan Munkarah As New Executive Vice President & Chief Clinical Officer 271
  • 6.34 Mar 01, 2018: Nemaura Announces Expansion of Manufacturing Capabilities for SugarBEAT Commercial Launch 272
  • 6.35 Mar 01, 2018: Senseonics Announces Date for FDA Advisory Panel 272
  • 6.36 Mar 01, 2018: Tandem Diabetes Care Announces 2017 Financial Results 273
  • 6.37 Mar 01, 2018: Senseonics Announces Date for FDA Advisory Panel 274
  • 6.38 Mar 01, 2018: Callitas Health Has Big Plans For Broad Product Portfolio 275
  • 6.39 Feb 21, 2018: Insulet Reports Fourth Quarter Revenue of $130.5 Million In Fourth Quarter Of 2017 276
  • 6.40 Feb 21, 2018: Veritas Pharma Provides Corporate Update on Q1 2018 278
  • 6.41 Feb 20, 2018: Eversense CGM System, World's Longest Lasting CGM Sensor, Announces Approval and Launch of Remote Monitoring Feature for EMEA Markets 279
  • 6.42 Feb 20, 2018: New Study Demonstrates that DexCom CGM Significantly Reduces Hypoglycaemia in People with Type 1 Diabetes on MDI 279
  • 6.43 Feb 20, 2018: New study shows that DexCom CGM significantly reduces hypoglycaemia in people with type 1 diabetes with multiple daily insulin injections (MDI) 280
  • 6.44 Feb 20, 2018: DarioHealth Launches Sales of Dario Blood Glucose Monitoring System on Amazon Prime 281
  • 6.45 Feb 20, 2018: Henry Schein Reports Record Fourth Quarter and Full Year 2017 Financial Results 282
  • 6.46 Feb 19, 2018: Henry Schein And Its Dental Laboratory Business, Zahn Dental, To Showcase The Company's Latest Digital Solutions At Chicago Midwinter Dental Meeting And LMT Lab Day 284
  • 6.47 Feb 16, 2018: Senzime's Year-end Bulletin 2017 285
  • 6.48 Feb 15, 2018: ProAxsis reaches the commercialization stage of its technology by reporting its first NEATstik sale 286
  • 6.49 Feb 15, 2018: ConvaTec Group Annual Results 2017 286
  • 6.50 Feb 15, 2018: ConvaTec Group Reports Annual Financial Results For 2017 288
  • 6.51 Feb 14, 2018: Ericsson, Sony Mobile and Altair Announce LTE-M eHealth Concept Demo 293
  • 6.52 Feb 13, 2018: Henry Schein Denies FTC Anti-Trust Allegations 294
  • 6.53 Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program 295
  • 6.54 Feb 13, 2018: Changing Health and Ascensia Team up to Offer Game-changing Diabetes Support 295
  • 6.55 Feb 12, 2018: DarioHealth Partners with a Leading Diabetes Clinic 295
  • 6.56 Feb 12, 2018: Henry Schein Named one of the 2018 World's Most Ethical Companies by The Ethisphere Institute for the Seventh Time 296
  • 6.57 Feb 09, 2018: Nemaura Medical Reports Third Quarter 2017 Financial Results 297
  • 6.58 Feb 08, 2018: DarioHealth Wins Key Contract Ensuring Its Platform to be Utilized in Clinical Study 298
  • 6.59 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 298
  • 6.60 Feb 08, 2018: DarioHealth Wins Key Contract Ensuring Its Platform to be Utilized in Clinical Study 299
  • 6.61 Feb 08, 2018: Theraclion Accelerates its Growth in 2017 299
  • 6.62 Feb 07, 2018: Sanofi Delivers 2017 Business EPS in line with Guidance 301
  • 6.63 Feb 07, 2018: Theraclion announces the reinforcement of its Board of Directors with the nomination of a new Non-Executive Director: Mister Renaud Saleur 303
  • 6.64 Feb 01, 2018: Roche reports good results in 2017 303
  • 6.65 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results 304

7 Appendix 498

  • 7.1 Methodology 498
  • 7.2 About GlobalData 501
  • 7.3 Contact Us 501
  • 7.4 Disclaimer 501

List of Tables

1.1 List of Tables

  • Table 1: Blood Glucose Meters - Pipeline Products by Stage of Development 26
  • Table 2: Blood Glucose Meters - Pipeline Products by Segment 27
  • Table 3: Blood Glucose Meters - Pipeline Products by Territory 28
  • Table 4: Blood Glucose Meters - Pipeline Products by Regulatory Path 29
  • Table 5: Blood Glucose Meters - Pipeline Products by Estimated Approval Date 30
  • Table 6: Blood Glucose Meters - Ongoing Clinical Trials 31
  • Table 7: Blood Glucose Meters Companies - Pipeline Products by Stage of Development 32
  • Table 8: Blood Glucose Meters - Pipeline Products by Stage of Development 36
  • Table 9: 4a Medicom GmbH Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 10: GlucoPEARL - Product Status 41
  • Table 11: GlucoPEARL - Product Description 41
  • Table 12: A. Menarini Diagnostics Srl Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 13: GlucoMen Day - Product Status 42
  • Table 14: GlucoMen Day - Product Description 42
  • Table 15: Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 16: FreeStyle Libre Flash Glucose Monitoring System - Children - Product Status 43
  • Table 17: FreeStyle Libre Flash Glucose Monitoring System - Children - Product Description 43
  • Table 18: FreeStyle Libre Glucose Monitoring System - Consumer Version - Product Status 44
  • Table 19: FreeStyle Libre Glucose Monitoring System - Consumer Version - Product Description 44
  • Table 20: Abbott Diabetes Care Inc - Ongoing Clinical Trials Overview 45
  • Table 21: FreeStyle Libre Flash Glucose Monitoring System - Children - A Comparative Study on the Accuracy, Ease of Use and Skin Reactions Between the Enlite Sensor With Guardian 2 Link Transmitter and the FreeStyle Libre Flash Glucose Sensor 46
  • Table 22: FreeStyle Libre Flash Glucose Monitoring System - Children - An Evaluation of the Usability, Skin Reactions and Accuracy of the FreeStyle Libre Flash Glucose Monitoring System 46
  • Table 23: FreeStyle Libre Flash Glucose Monitoring System - Children - Effectiveness and Safety Study of the FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations 46
  • Table 24: FreeStyle Libre Flash Glucose Monitoring System - Children - Evaluation of Two Different Glucose Monitoring Treatments and Their Impact on Time in Target, Sleep and Quality of Life in Children with Type 1 Diabetes and Primary Caregivers 47
  • Table 25: FreeStyle Libre Flash Glucose Monitoring System - Children - FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients 47
  • Table 26: FreeStyle Libre Flash Glucose Monitoring System - Children - Paediatric Use of the Abbott Sensor Based Glucose Monitoring System - an Accuracy Evaluation 47
  • Table 27: FreeStyle Libre Flash Glucose Monitoring System - Children - Patients Perceptions of Using the Libre System Compared with Conventional SMBG in Adolescents with Type 1 Diabetes the Libre Sat Trial 48
  • Table 28: FreeStyle Libre Glucose Monitoring System - Consumer Version - Study about the Discrepancies Between Monitoring Data of FreeStyle libre and SMBG 49
  • Table 29: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 30: Updated Hospital Blood Glucose Monitoring System - Product Status 50
  • Table 31: Updated Hospital Blood Glucose Monitoring System - Product Description 50
  • Table 32: Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 33: My Medibit - Product Status 51
  • Table 34: My Medibit - Product Description 51
  • Table 35: Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 36: Continuous Glucose Monitor - Product Status 52
  • Table 37: Continuous Glucose Monitor - Product Description 52
  • Table 38: Animas Corp Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 39: Next Generation OneTouch UltraVue Verio Platform Glucose Testing System - Product Status 53
  • Table 40: Next Generation OneTouch UltraVue Verio Platform Glucose Testing System - Product Description 53
  • Table 41: Arkal Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 42: GlucoPod CGM System - Product Status 54
  • Table 43: GlucoPod CGM System - Product Description 54
  • Table 44: Arkray Inc Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 45: GLUCOCARD S - Product Status 55
  • Table 46: GLUCOCARD S - Product Description 55
  • Table 47: GLUCOCARD S onyx - Product Status 56
  • Table 48: GLUCOCARD S onyx - Product Description 56
  • Table 49: GLUCOCARD W - Product Status 56
  • Table 50: GLUCOCARD W - Product Description 56
  • Table 51: Ascensia Diabetes Care Holdings AG Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 52: CONTOUR PLUS ONE - Product Status 57
  • Table 53: CONTOUR PLUS ONE - Product Description 57
  • Table 54: Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 55: Blood Glucose Sensor - Product Status 58
  • Table 56: Blood Glucose Sensor - Product Description 58
  • Table 57: Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 58: Biometric Watch - Product Status 59
  • Table 59: Biometric Watch - Product Description 59
  • Table 60: Baylor University Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 61: Portable Non-Invasive Blood Glucose Monitor - Product Status 60
  • Table 62: Portable Non-Invasive Blood Glucose Monitor - Product Description 60
  • Table 63: Biopeak Corp Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 64: Non-Invasive Glucose Analyzer - Product Status 61
  • Table 65: Non-Invasive Glucose Analyzer - Product Description 61
  • Table 66: Biorasis Inc Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 67: Glucowizzard - Product Status 62
  • Table 68: Glucowizzard - Product Description 62
  • Table 69: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 70: Smart Tattoo Glucose Sensor - Product Status 63
  • Table 71: Smart Tattoo Glucose Sensor - Product Description 63
  • Table 72: Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 73: VSM 3 Glucose Monitoring System - Product Status 64
  • Table 74: VSM 3 Glucose Monitoring System - Product Description 64
  • Table 75: Brain Beat Ltd Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 76: Non-Invasive Glucometer - Product Status 65
  • Table 77: Non-Invasive Glucometer - Product Description 65
  • Table 78: Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 79: Fluorescence Measurement Device - Product Status 66
  • Table 80: Fluorescence Measurement Device - Product Description 66
  • Table 81: Cactus Semiconductor Inc Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 82: Blood Glucose Monitor - Product Status 67
  • Table 83: Blood Glucose Monitor - Product Description 67
  • Table 84: CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 85: Glucoband - Product Status 68
  • Table 86: Glucoband - Product Description 68
  • Table 87: Callitas Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 69
  • Table 88: Electronic Mosquito - Product Status 69
  • Table 89: Electronic Mosquito - Product Description 69
  • Table 90: Cardiff University Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 91: Non-Invasive Blood Glucose Meter - Product Status 70
  • Table 92: Non-Invasive Blood Glucose Meter - Product Description 70
  • Table 93: CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 94: Miniaturized Implantable Continuous Glucose Monitor - Product Status 71
  • Table 95: Miniaturized Implantable Continuous Glucose Monitor - Product Description 71
  • Table 96: City, University of London Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 97: Non-Invasive Glucose Monitor - Product Status 72
  • Table 98: Non-Invasive Glucose Monitor - Product Description 72
  • Table 99: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 100: Wearable Continuous Blood Glucose Monitoring Device - Product Status 73
  • Table 101: Wearable Continuous Blood Glucose Monitoring Device - Product Description 73
  • Table 102: ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 103: Closed Loop Continuous Glucose Monitoring System - Product Status 74
  • Table 104: Closed Loop Continuous Glucose Monitoring System - Product Description 74
  • Table 105: Cyber Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 106: Cybersensors Continuous Glucose Sensor - Product Status 75
  • Table 107: Cybersensors Continuous Glucose Sensor - Product Description 75
  • Table 108: DarioHealth Corp Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 109: Dario Blood Glucose Monitoring System - Lightning Enabled Version - Product Status 76
  • Table 110: Dario Blood Glucose Monitoring System - Lightning Enabled Version - Product Description 76
  • Table 111: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 112: Integrated iSense CGM And JewelPUMP - Product Status 77
  • Table 113: Integrated iSense CGM And JewelPUMP - Product Description 77
  • Table 114: DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 115: DexCom CGM With Accu-Chek Insulin Delivery System - Product Status 78
  • Table 116: DexCom CGM With Accu-Chek Insulin Delivery System - Product Description 79
  • Table 117: Dexcom G5x - Product Status 79
  • Table 118: Dexcom G5x - Product Description 79
  • Table 119: First-Gen Verily Sensor - Product Status 79
  • Table 120: First-Gen Verily Sensor - Product Description 80
  • Table 121: G6 Continuous Glucose Monitor - Product Status 80
  • Table 122: G6 Continuous Glucose Monitor - Product Description 80
  • Table 123: Second-Gen Verily Sensor - Product Status 80
  • Table 124: Second-Gen Verily Sensor - Product Description 81
  • Table 125: DexCom Inc - Ongoing Clinical Trials Overview 82
  • Table 126: DexCom CGM With Accu-Chek Insulin Delivery System - Closed-loop Glucagon Pump for Treatment of Post-bariatric Hypoglycemia 83
  • Table 127: DexCom CGM With Accu-Chek Insulin Delivery System - Wireless Innovation for Seniors with Diabetes Mellitus: WISDM 83
  • Table 128: Dexcom G5x - Closed-loop Glucagon Pump for Treatment of Post-bariatric Hypoglycemia 84
  • Table 129: DiaMonTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 130: Infrared Laser Glucometer - Home Use - Product Status 85
  • Table 131: Infrared Laser Glucometer - Home Use - Product Description 85
  • Table 132: Infrared Laser Glucometer - Wearable - Product Status 86
  • Table 133: Infrared Laser Glucometer - Wearable - Product Description 86
  • Table 134: DIRAmed LLC. Pipeline Products & Ongoing Clinical Trials Overview 87
  • Table 135: Critical Care Glucose Monitor - Hospital Use - Product Status 87
  • Table 136: Critical Care Glucose Monitor - Hospital Use - Product Description 87
  • Table 137: Glucose Monitor - Home Use - Product Status 88
  • Table 138: Glucose Monitor - Home Use - Product Description 88
  • Table 139: DirectSens GmbH Pipeline Products & Ongoing Clinical Trials Overview 89
  • Table 140: Continuous Blood Glucose Monitoring System - Product Status 89
  • Table 141: Continuous Blood Glucose Monitoring System - Product Description 89
  • Table 142: Drayson Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 90
  • Table 143: GDm-Health Management System - Product Status 90
  • Table 144: GDm-Health Management System - Product Description 90
  • Table 145: Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 91
  • Table 146: Gen 2 Symphony CGM System - Product Status 91
  • Table 147: Gen 2 Symphony CGM System - Product Description 91
  • Table 148: NextGen System - Product Status 92
  • Table 149: NextGen System - Product Description 92
  • Table 150: Symphony tCGM System - Home - Product Status 92
  • Table 151: Symphony tCGM System - Home - Product Description 93
  • Table 152: Symphony tCGM System - Hospital Critical Care - Product Status 93
  • Table 153: Symphony tCGM System - Hospital Critical Care - Product Description 93
  • Table 154: Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 94

List of Figures

1.2 List of Figures

  • Figure 1: Blood Glucose Meters - Pipeline Products by Stage of Development 26
  • Figure 2: Blood Glucose Meters - Pipeline Products by Segment 27
  • Figure 3: Blood Glucose Meters - Pipeline Products by Territory 28
  • Figure 4: Blood Glucose Meters - Pipeline Products by Regulatory Path 29
  • Figure 5: Blood Glucose Meters - Pipeline Products by Estimated Approval Date 30
  • Figure 6: Blood Glucose Meters - Ongoing Clinical Trials 31
Back to Top